Form 4 for LH Labcorp
Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-02 · accession 0001127602-23-003544 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-06 | 2023-02-02 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +237 | 5,578 | +4% | — |
| D | 2023-02-06 | 2023-02-03 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $253.90 | -173 | 5,341 | -3% | -$43.9K |
| D | 2023-02-06 | 2023-02-02 | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $254.99 | -64 | 5,514 | -1% | -$16.3K |
| D | 2023-02-06 | 2023-02-02 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | $0.00 | -237 | 1,407 | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-02 | M | A | 237 | — | 5,577.76 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F2) Amount includes 26.2103 shares acquired on June 30, 2022 and 27.5309 shares acquired on December 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-02-03 | S | D | 173 | $253.90 | 5,340.76 | D | — | — | (F2) Amount includes 26.2103 shares acquired on June 30, 2022 and 27.5309 shares acquired on December 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2023-02-02 | F | D | 64 | $254.99 | 5,513.76 | D | — | — | (F2) Amount includes 26.2103 shares acquired on June 30, 2022 and 27.5309 shares acquired on December 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. |
| 4 | Derivative | Restricted Stock Unit | 2023-02-02 | M | D | 237 | $0.00 | 1,407 | D | — · — to — | 237 Common Stock | (F6) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F5) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022. |